title: [Treatment of inflammatory and proliferative skin diseases].
abstract: Treatment of inflammatory and proliferation dermatoses can now be accomplished with pharmacologic agents which inhibit production of mediators or their actions. The immune system can be stimulated by thymosin, imidazo drugs, BCG, corynebacterium parvum and idoxyuridine. Immune complex diseases may be treated with corticosteroids, clofazimine, sulfonamides, antimalarial drugs, and nicotinic acid. Low dose, safe immunosuppressive therapy can successfully control scleromyxedema, guttate parapsoriasis, histiocytosis X, Kaposi's sarcoma, and Sézary syndrome.
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003872:Dermatitis / Q000188:drug therapy*; D003873:Dermatitis, Exfoliative / Q000188:drug therapy; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy; D006801:Humans; D007645:Keratoderma, Palmoplantar / Q000188:drug therapy; D008206:Lymphatic Diseases / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D012514:Sarcoma, Kaposi / Q000188:drug therapy; D012872:Skin Diseases, Vesiculobullous / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy*; D013577:Syndrome
chemical_list: D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents
vernacular_title: Zur Therapie entzündlicher und proliferativer Hauterkrankungen.